Table 3 Changes in API before and after surgery for patients with negative TM levels before surgery
(a) | ||||
Negative TM presurgery | Histology | No. of patients (pre API ≥ 6) | No. of API normalized cases (post API < 6) | Normalization rate |
SCC | All | 40 | 34 | 85.0% |
CA125 | All | 60 | 54 | 90.0% |
CEA | All | 79 | 71 | 89.9% |
CA19–9 | All | 63 | 57 | 90.5% |
CEA, CA19–9, CA125 | All | 46 | 43 | 93.5% |
(b) | ||||
Negative TM presurgery | Histology | No. of patients (pre API ≥ 6) | No. of API normalized cases (post API < 6) | Normalization rate |
SCC | Squamous cell Carcinoma | 1 | 1 | 100% |
CA125 | Adenocarcinoma | 52 | 47 | 90.4% |